1. Home
  2. CINT vs SPRY Comparison

CINT vs SPRY Comparison

Compare CINT & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CI&T Inc

CINT

CI&T Inc

SELL

Current Price

$3.11

Market Cap

391.6M

Sector

Technology

ML Signal

SELL

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

SELL

Current Price

$4.18

Market Cap

404.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CINT
SPRY
Founded
1995
2015
Country
Brazil
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
391.6M
404.8M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
CINT
SPRY
Price
$3.11
$4.18
Analyst Decision
Buy
Strong Buy
Analyst Count
10
4
Target Price
$5.62
★ $22.50
AVG Volume (30 Days)
55.4K
★ 1.4M
Earning Date
11-11-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $84,278,000.00
Revenue This Year
$16.56
$54.14
Revenue Next Year
$9.87
$46.73
P/E Ratio
$17.94
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$2.80
$4.00
52 Week High
$6.06
$13.15

Technical Indicators

Market Signals
Indicator
CINT
SPRY
Relative Strength Index (RSI) 46.66 40.41
Support Level $2.81 $4.00
Resistance Level $3.62 $4.57
Average True Range (ATR) 0.16 0.27
MACD 0.02 0.07
Stochastic Oscillator 46.03 32.28

Price Performance

Historical Comparison
CINT
SPRY

About CINT CI&T Inc

CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: